Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 421

1.

Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT.

Hong HH, Dunnick J, Herbert R, Devereux TR, Kim Y, Sills RC.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):299-306. Erratum in: Environ Mol Mutagen. 2007 Jul;48(6):501.

PMID:
16395694
2.

K-ras cancer gene mutations in lung tumors from female Swiss (CD-1) mice exposed transplacentally to 3'-azido-3'-deoxythymidine.

Koujitani T, Ton TV, Lahousse SA, Hong HH, Wakamatsu N, Sills RC.

Environ Mol Mutagen. 2008 Dec;49(9):720-6. doi: 10.1002/em.20420.

PMID:
18800350
3.

Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months.

Sills RC, Hong HL, Greenwell A, Herbert RA, Boorman GA, Devereux TR.

Carcinogenesis. 1995 Jul;16(7):1623-8.

PMID:
7614698
4.

Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.

Zhang Z, Diwan BA, Anderson LM, Logsdon D, Olivero OA, Haines DC, Rice JM, Yuspa SH, Poirier MC.

Mol Carcinog. 1998 Sep;23(1):45-51.

PMID:
9766437
5.

Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene.

Hong HH, Ton TV, Kim Y, Wakamatsu N, Clayton NP, Chan PC, Sills RC, Lahousse SA.

Toxicol Pathol. 2008 Jul;36(5):720-6. doi: 10.1177/0192623308320280. Epub 2008 Jul 22.

6.

Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.

Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):297-302. Erratum in: Cancer Epidemiol Biomarkers Prev 2001 Dec;10(12):1309.

7.

Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.

Walker DM, Malarkey DE, Seilkop SK, Ruecker FA, Funk KA, Wolfe MJ, Treanor CP, Foley JF, Hahn FF, Hardisty JF, Walker VE.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):283-98.

PMID:
17358026
8.

High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.

Hayashi S, Hong HH, Toyoda K, Ton TV, Devereux TR, Maronpot RR, Huff J, Sills RC.

Toxicol Pathol. 2001 Jul-Aug;29(4):422-9.

9.

Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years.

Hong HH, Devereux TR, Melnick RL, Moomaw CR, Boorman GA, Sills RC.

Toxicol Pathol. 2000 Jul-Aug;28(4):529-34.

10.

Molecular pathogenesis of transplacentally induced mouse lung tumors.

Miller MS, Leone-Kabler S, Rollins LA, Wessner LL, Fan M, Schaeffer DO, McEntee MF, O'Sullivan MG.

Exp Lung Res. 1998 Jul-Aug;24(4):557-77. Review.

PMID:
9659583
11.

Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride.

Devereux TR, Foley JF, Maronpot RR, Kari F, Anderson MW.

Carcinogenesis. 1993 May;14(5):795-801.

PMID:
8504471
12.

Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.

Goodrow T, Reynolds S, Maronpot R, Anderson M.

Cancer Res. 1990 Aug 1;50(15):4818-23.

13.

Analysis of K-ras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors.

Nickell-Brady C, Hahn FF, Finch GL, Belinsky SA.

Carcinogenesis. 1994 Feb;15(2):257-62.

PMID:
7545909
14.

Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.

Chan SS, Santos JH, Meyer JN, Mandavilli BS, Cook DL Jr, McCash CL, Kissling GE, Nyska A, Foley JF, van Houten B, Copeland WC, Walker VE, Witt KL, Bishop JB.

Environ Mol Mutagen. 2007 Apr-May;48(3-4):190-200.

PMID:
16395692
15.

Predominant K-ras codon 12 G --> A transition in chemically induced lung neoplasms in B6C3F1 mice.

Ton TV, Hong HH, Anna CH, Dunnick JK, Devereux TR, Sills RC, Kim Y.

Toxicol Pathol. 2004 Jan-Feb;32(1):16-21.

16.
18.

Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.

Vatan O, Bilaloglu R, Tunca B, Cecener G, Gebitekin C, Egeli U, Yakut T, Urer N.

Tumori. 2007 Sep-Oct;93(5):473-7.

19.

Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.

Bongiorno PF, Whyte RI, Lesser EJ, Moore JH, Orringer MB, Beer DG.

J Thorac Cardiovasc Surg. 1994 Feb;107(2):590-5.

PMID:
7905543
20.

Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene.

Shafarenko M, Mahler J, Cochran C, Kisielewski A, Golding E, Wiseman R, Goodrow T.

Carcinogenesis. 1997 Jul;18(7):1423-6.

Items per page

Supplemental Content

Write to the Help Desk